BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 23892893)

  • 1. Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death.
    Magnaghi P; D'Alessio R; Valsasina B; Avanzi N; Rizzi S; Asa D; Gasparri F; Cozzi L; Cucchi U; Orrenius C; Polucci P; Ballinari D; Perrera C; Leone A; Cervi G; Casale E; Xiao Y; Wong C; Anderson DJ; Galvani A; Donati D; O'Brien T; Jackson PK; Isacchi A
    Nat Chem Biol; 2013 Sep; 9(9):548-56. PubMed ID: 23892893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric p97 Inhibitors Can Overcome Resistance to ATP-Competitive p97 Inhibitors for Potential Anticancer Therapy.
    Wang F; Li S; Gan T; Stott GM; Flint A; Chou TF
    ChemMedChem; 2020 Apr; 15(8):685-694. PubMed ID: 32162487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p97 Composition Changes Caused by Allosteric Inhibition Are Suppressed by an On-Target Mechanism that Increases the Enzyme's ATPase Activity.
    Her NG; Toth JI; Ma CT; Wei Y; Motamedchaboki K; Sergienko E; Petroski MD
    Cell Chem Biol; 2016 Apr; 23(4):517-28. PubMed ID: 27105284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.
    Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF
    Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VCP inhibitors induce endoplasmic reticulum stress, cause cell cycle arrest, trigger caspase-mediated cell death and synergistically kill ovarian cancer cells in combination with Salubrinal.
    Bastola P; Neums L; Schoenen FJ; Chien J
    Mol Oncol; 2016 Dec; 10(10):1559-1574. PubMed ID: 27729194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
    Bursavich MG; Parker DP; Willardsen JA; Gao ZH; Davis T; Ostanin K; Robinson R; Peterson A; Cimbora DM; Zhu JF; Richards B
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1677-9. PubMed ID: 20137940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.
    Chou TF; Bulfer SL; Weihl CC; Li K; Lis LG; Walters MA; Schoenen FJ; Lin HJ; Deshaies RJ; Arkin MR
    J Mol Biol; 2014 Jul; 426(15):2886-99. PubMed ID: 24878061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMS-873 functions as a dual inhibitor of mitochondrial oxidative phosphorylation.
    Bouwer MF; Hamilton KE; Jonker PB; Kuiper SR; Louters LL; Looyenga BD
    Biochimie; 2021 Jun; 185():33-42. PubMed ID: 33727138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.
    Lan B; Chai S; Wang P; Wang K
    Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
    Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
    Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP.
    Wang Q; Song C; Yang X; Li CC
    J Biol Chem; 2003 Aug; 278(35):32784-93. PubMed ID: 12807884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimer-Based Selective Proteostasis-Inhibition Strategy to Control NSCLC Growth and Progression.
    Walworth K; Bodas M; Campbell RJ; Swanson D; Sharma A; Vij N
    PLoS One; 2016; 11(7):e0158507. PubMed ID: 27434122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Role for VCP/p97 in the Processing of Drug-Stabilized TOP2-DNA Covalent Complexes.
    Swan RL; Cowell IG; Austin CA
    Mol Pharmacol; 2021 Jul; 100(1):57-62. PubMed ID: 33941661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells.
    Kobayashi T; Tanaka K; Inoue K; Kakizuka A
    J Biol Chem; 2002 Dec; 277(49):47358-65. PubMed ID: 12351637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkylsulfanyl-1,2,4-triazoles, a new class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships.
    Polucci P; Magnaghi P; Angiolini M; Asa D; Avanzi N; Badari A; Bertrand J; Casale E; Cauteruccio S; Cirla A; Cozzi L; Galvani A; Jackson PK; Liu Y; Magnuson S; Malgesini B; Nuvoloni S; Orrenius C; Sirtori FR; Riceputi L; Rizzi S; Trucchi B; O'Brien T; Isacchi A; Donati D; D'Alessio R
    J Med Chem; 2013 Jan; 56(2):437-50. PubMed ID: 23245311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATPase activity of p97/valosin-containing protein is regulated by oxidative modification of the evolutionally conserved cysteine 522 residue in Walker A motif.
    Noguchi M; Takata T; Kimura Y; Manno A; Murakami K; Koike M; Ohizumi H; Hori S; Kakizuka A
    J Biol Chem; 2005 Dec; 280(50):41332-41. PubMed ID: 16234241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 2-(cyclohexylmethylamino)pyrimidines as a new class of reversible valosine containing protein inhibitors.
    Cervi G; Magnaghi P; Asa D; Avanzi N; Badari A; Borghi D; Caruso M; Cirla A; Cozzi L; Felder E; Galvani A; Gasparri F; Lomolino A; Magnuson S; Malgesini B; Motto I; Pasi M; Rizzi S; Salom B; Sorrentino G; Troiani S; Valsasina B; O'Brien T; Isacchi A; Donati D; D'Alessio R
    J Med Chem; 2014 Dec; 57(24):10443-54. PubMed ID: 25474526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase.
    Segura-Cabrera A; Tripathi R; Zhang X; Gui L; Chou TF; Komurov K
    Sci Rep; 2017 Mar; 7():44912. PubMed ID: 28322292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms Driving and Regulating the AAA+ ATPase VCP/p97, an Important Therapeutic Target for Treating Cancer, Neurological and Infectious Diseases.
    Valimehr S; Sethi A; Shukla M; Bhattacharyya S; Kazemi M; Rouiller I
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and function of the AAA+ ATPase p97/Cdc48p.
    Xia D; Tang WK; Ye Y
    Gene; 2016 May; 583(1):64-77. PubMed ID: 26945625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.